Registry study for people with new heart disease and type 2 diabetes
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study records health information to understand how type 2 diabetes and newly diagnosed heart disease affect people over time. It may help doctors learn what to watch for and how to plan care, though it is mainly an observational registry.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- You have been newly diagnosed with heart disease (for example, heart artery disease or heart failure)
- Your heart disease must be new—not something you had before
- You are not enrolled if you do not have type 2 diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information about people with diabetes to better understand the condition in everyday life. It may help improve future diabetes care by building a real-world diabetes database.
This study is a health registry that collects information about risk factors for heart and metabolic problems in adults. It may help doctors better understand who is at higher risk and guide future prevention strategies.
This study sets up a diabetes registry, which means collecting information about people’s diabetes care in a hospital clinic. It may help improve understanding of how diabetes is managed in real life, which can support better future care.
This study looks at how newly diagnosed type 2 diabetes affects heart and blood vessel health. Researchers will follow patients over time to understand the relationship between diabetes and cardiovascular risk.
This study creates a registry to collect information about diabetes patients. It helps doctors understand the condition better and may lead to improved care.
This is a registry (a study that collects health information) for people with certain heart and blood vessel conditions. It may help researchers better understand who has these diseases, how they are managed, and outcomes over time.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.